Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C)

CONCLUSION: Using N3C, we assembled the largest nationally representative cohort of patients with cancer and COVID-19 to date. We identified demographic and clinical factors associated with increased all-cause mortality in patients with cancer. Full characterization of the cohort will provide further insights into the effects of COVID-19 on cancer outcomes and the ability to continue specific cancer treatments.PMID:34085538 | DOI:10.1200/JCO.21.01074

Source: Clinical Genitourinary Cancer - June 4, 2021 Category: Cancer & Oncology Authors: Noha Sharafeldin Benjamin Bates Qianqian Song Vithal Madhira Yao Yan Sharlene Dong Eileen Lee Nathaniel Kuhrt Yu Raymond Shao Feifan Liu Timothy Bergquist Justin Guinney Jing Su Umit Topaloglu Source Type: research